Posted by jade k on July 17, 2010, at 7:01:16
In reply to AD augmentation with AAPs, posted by Bob on July 12, 2010, at 16:30:09
> I'm always seeing advertisements for Otsuka and Bristol-Myers Squibb's Abilify indicating it as an augmentation to the popular SSRI/SNRI antidepressants. Why don't I see similar indications for Janssen's Risperdal? Has Abilify proven more effective as an adjunct in this regard than Risperdal? Is one of them easier to tolerate than the other?
>
> -BobHi Bob,
I had reservations when I saw all the ads for abilify a/d augmentation. I have to say though I've talked to enough people using it successfully, for that purpose, that I'm a believer. Haven't heard of anyone using Risperdal for that. Probably a reason.
~Jade
poster:jade k
thread:954239
URL: http://www.dr-bob.org/babble/20100709/msgs/954743.html